HOME › DRUGS › NALTREXONE HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

NALTREXONE HYDROCHLORIDE

Brand name(s): REVIA, EMBEDA, NALTREXONE HYDROCHLORIDE, CONTRAVE, NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE, TROXYCA ER
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA200063
NDA207621
ACTIVE SUBSTANCE
Naltrexone Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
NALPROPION, BARR, NOVITIUM PHARMA
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TROXYCA ERNDA207621PFIZERDiscontinued
NALTREXONE HYDROCHLORIDEANDA074918BARRPrescription
NALTREXONE HYDROCHLORIDEANDA075434NOVITIUM PHARMADiscontinued
CONTRAVENDA200063NALPROPIONPrescription
NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDEANDA208043ACTAVIS LABS FL INCNone (Tentative Approval)
REVIANDA018932TEVA WOMENSDiscontinued
EMBEDANDA022321ALPHARMA PHARMSDiscontinued

FULL INTELLIGENCE ON NALTREXONE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →